AI-generated analysis. Always verify with the original filing.
PDS Biotechnology Corporation issued a press release on February 20, 2026, announcing the adoption of a protocol amendment under Item 8.01. The press release is filed as Exhibit 99.1.
Event Type
Disclosure
Voluntary
Variant
8-K
Other Events. On February 20, 2026, PDS Biotechnology Corporation (the “Company”) issued a press release announcing the adoption of a protocol amendment to its
Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Press Release Dated February 20, 2026. 104 Cover Page Interactive Data File (em